ACR Convergence 2026 has ended. This guide stays up as the record of who was there. See upcoming conferences
Tonix Medicines at ACR Convergence 2026
Nov 6–11, 2026 Orlando, FL ~15k attendees Website
Tonix Medicines brings 2 presentations to ACR Convergence 2026 in Orlando, and exhibits at Booth 1613. Its program centres on Tonmya, a sublingual cyclobenzaprine tablet for fibromyalgia. It covers pooled phase 3 results on the likelihood of benefit versus harm, and what the first FDA-approved fibromyalgia treatment in over 15 years means for adult patients.
| Organization | ACR Convergence 2026 Attendance |
|---|---|
Tonix Medicines Berkeley Heights, NJ | |
Commercial subsidiary of Tonix Pharmaceuticals with products for fibromyalgia and migraine. | Booth Exhibiting at Booth 1613 Sun, Nov 810:00am–5:00pmMon, Nov 910:00am–5:00pmTue, Nov 1010:00am–2:30pm Poster Tue Nov 10 10:30am–12:30pm Industry Tue Nov 10 10:30am–11:15am What the First FDA-Approved Treatment for Fibromyalgia in Over 15 Years Means for Your Adult Patients |
Find decision makers at Tonix Medicines
Tell us what you sell and we’ll find the people at Tonix Medicines most likely to buy it.
- Who to contact
- Their contact info
- What to say
- Free, no sign-up
Not affiliated with or endorsed by the American College of Rheumatology (ACR). Organization details are derived from the ACR’s published program and exhibitor floor plan, and each organization’s own website. Submit a correction